Glaxo to Begin Hostile Offer for Human Genome at $13 a Share

Glaxo to Begin Hostile Offer for Human Genome at $13 a Share

GlaxoSmithKline Plc via Bloomberg

The headquarters of GlaxoSmithKline Plc stand in Brentford.